Catalpol protects vascular structure and promotes angiogenesis in cerebral ischemic rats by targeting HIF-1α/VEGF.

[1]  Huifeng Zhu,et al.  Catalpol induces cell activity to promote axonal regeneration via the PI3K/AKT/mTOR pathway in vivo and in vitro stroke model. , 2019, Annals of translational medicine.

[2]  S. Gerecht,et al.  Role of iPSC-derived pericytes on barrier function of iPSC-derived brain microvascular endothelial cells in 2D and 3D , 2019, Fluids and Barriers of the CNS.

[3]  Xiaoyu Xu,et al.  Knockdown of HIF‐1α impairs post‐ischemic vascular reconstruction in the brain via deficient homing and sprouting bmEPCs , 2018, Brain pathology.

[4]  N. Hooper,et al.  Tissue Engineering 3D Neurovascular Units: A Biomaterials and Bioprinting Perspective. , 2018, Trends in biotechnology.

[5]  S. Gerecht,et al.  Engineering the human blood-brain barrier in vitro , 2017, Journal of Biological Engineering.

[6]  Szu-Fu Chen,et al.  Low-intensity pulsed ultrasound improves behavioral and histological outcomes after experimental traumatic brain injury , 2017, Scientific Reports.

[7]  C. Iadecola.  The Neurovascular Unit Coming of Age: A Journey through Neurovascular Coupling in Health and Disease , 2017, Neuron.

[8]  R. Lipton,et al.  Association Between Vascular Pathology and Rate of Cognitive Decline Independent of Alzheimer's Disease Pathology , 2017, Journal of the American Geriatrics Society.

[9]  Luca Cucullo,et al.  New experimental models of the blood-brain barrier for CNS drug discovery , 2017, Expert opinion on drug discovery.

[10]  L. Zhiqiang,et al.  Catalpol stimulates VEGF production via the JAK2/STAT3 pathway to improve angiogenesis in rats' stroke model. , 2016, Journal of ethnopharmacology.

[11]  U. Meyding-Lamadé,et al.  Immortalized endothelial cell lines for in vitro blood–brain barrier models: A systematic review , 2016, Brain Research.

[12]  B. Zlokovic,et al.  Neurovascular dysfunction and neurodegeneration in dementia and Alzheimer's disease. , 2016, Biochimica et biophysica acta.

[13]  A. Lazou,et al.  Oxygen–Glucose Deprivation (OGD) Modulates the Unfolded Protein Response (UPR) and Inflicts Autophagy in a PC12 Hypoxia Cell Line Model , 2015, Cellular and Molecular Neurobiology.

[14]  T. Hinchliffe,et al.  Catalpol: a potential therapeutic for neurodegenerative diseases. , 2015, Current medicinal chemistry.

[15]  Mandy B. Esch,et al.  TEER Measurement Techniques for In Vitro Barrier Model Systems , 2015, Journal of laboratory automation.

[16]  Stefan Roth,et al.  Modeling Stroke in Mice: Permanent Coagulation of the Distal Middle Cerebral Artery , 2014, Journal of visualized experiments : JoVE.

[17]  R. Anne Stetler,et al.  Vascular remodeling after ischemic stroke: Mechanisms and therapeutic potentials , 2014, Progress in Neurobiology.

[18]  Chao-Ching Huang,et al.  Cerebral Microvascular Damage Occurs Early after Hypoxia–Ischemia via nNOS Activation in the Neonatal Brain , 2014, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[19]  Xiaoyu Xu,et al.  A simple method for isolating and culturing the rat brain microvascular endothelial cells. , 2013, Microvascular research.

[20]  R. Daneman.  The blood–brain barrier in health and disease , 2012, Annals of neurology.

[21]  Rui Zhang,et al.  Memory defect induced by beta-amyloid plus glutamate receptor agonist is alleviated by catalpol and donepezil through different mechanisms , 2012, Brain Research.

[22]  Xing-shu Chen,et al.  Protective effects of catalpol on oligodendrocyte death and myelin breakdown in a rat model of chronic cerebral hypoperfusion , 2011, Neuroscience Letters.

[23]  V. I. Skvortsova,et al.  The Significance of Toll-Like Receptors in the Development of Ischemic Damage , 2011, Neuroscience and Behavioral Physiology.

[24]  Huifeng Zhu,et al.  Catalpol Increases Brain Angiogenesis and Up-Regulates VEGF and EPO in the Rat after Permanent Middle Cerebral Artery Occlusion , 2010, International journal of biological sciences.

[25]  K. Hirschi,et al.  Diverse roles of the vasculature within the neural stem cell niche. , 2009, Regenerative medicine.

[26]  S. Liu,et al.  Catalpol ameliorates beta amyloid–induced degeneration of cholinergic neurons by elevating brain-derived neurotrophic factors , 2009, Neuroscience.

[27]  R. Jahan,et al.  Treatment of acute ischemic stroke: intravenous and endovascular therapies , 2009, Expert review of cardiovascular therapy.

[28]  Z. Jia,et al.  Rehmannia glutinosa: review of botany, chemistry and pharmacology. , 2008, Journal of ethnopharmacology.

[29]  T. Terasaki,et al.  Expression of nuclear receptor mRNA and liver X receptor-mediated regulation of ABC transporter A1 at rat blood–brain barrier , 2008, Neurochemistry International.

[30]  B. Zlokovic.  The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders , 2008, Neuron.

[31]  M. Chopp,et al.  Intracarotid transplantation of bone marrow stromal cells increases axon-myelin remodeling after stroke , 2006, Neuroscience.

[32]  J. Castillo,et al.  Vascular Protection in Brain Ischemia , 2006, Cerebrovascular Diseases.

[33]  J. Barker,et al.  Development of an Ischemic Tolerance Model in a PC12 Cell Line , 2005, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[34]  L. An,et al.  Neuroprotection of catalpol in transient global ischemia in gerbils , 2004, Neuroscience Research.

[35]  P. Carmeliet,et al.  VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[36]  N. Ferrara,et al.  The biology of VEGF and its receptors , 2003, Nature Medicine.

[37]  W. Pardridge,et al.  Drug and Gene Delivery to the Brain The Vascular Route , 2002, Neuron.

[38]  J. Broderick,et al.  Predicting prognosis after stroke , 2000, Neurology.

[39]  S. Ylä-Herttuala,et al.  Vascular protection: A novel nonangiogenic cardiovascular role for vascular endothelial growth factor. , 2000, Arteriosclerosis, thrombosis, and vascular biology.

[40]  A. Shuaib,et al.  Quantification of infarct size on focal cerebral ischemia model of rats using a simple and economical method , 1998, Journal of Neuroscience Methods.

[41]  U. Dirnagl,et al.  Induction of hypoxia inducible factor 1 by oxygen glucose deprivation is attenuated by hypoxic preconditioning in rat cultured neurons , 1998, Neuroscience Letters.

[42]  Y. Itoyama,et al.  Rapid induction of vascular endothelial growth factor gene expression after transient middle cerebral artery occlusion in rats. , 1997, Stroke.

[43]  S. Constantini,et al.  An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. , 1996, Journal of neurotrauma.

[44]  M. Goldberg,et al.  Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury , 1993, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[45]  D. Duverger,et al.  The Quantification of Cerebral Infarction following Focal Ischemia in the Rat: Influence of Strain, Arterial Pressure, Blood Glucose Concentration, and Age , 1988, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.

[46]  E. Hansson,et al.  Astrocyte–endothelial interactions at the blood–brain barrier , 2006, Nature Reviews Neuroscience.